ONOttar Nygård

Ottar Nygård

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ottar Nygård has a total of 164 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Gastrointestinal symptoms, faecal short-chain fatty acids and dietary intake in older adults: the Hordaland Health Study 3

    by Tilde Martinsen, Caroline Jensen, Jan Gunnar Hatlebakk, Jørgen Valeur, Ottar Nygård, Gülen Arslan Lied

    Purpose: Ageing is associated with a decline in gastrointestinal (GI) functions, but data on GI symptoms in older adults remain limited. This study assessed the prevalence of GI symptoms, irritable bowel syndrome (IBS), and faecal short-chain fatty acids (SCFAs) in older adults, and associations between GI symptoms and faecal SCFAs, dietary intake, and BMI. Methods: 907 older adults (66–69 years, 50.7% females) from the community-based Hordaland Health Study 3 − Microbiota study were included. GI symptoms and IBS status were assessed by validated questionnaires (Gastrointestinal Symptom Rating Scale, Rome IV-criteria, IBS-Severity Scoring System), dietary intake by a 279-item food frequency questionnaire, and the concentration of SCFAs were measured from faecal samples. Results: 33.9% experienced at least one GI symptom, 16.4% reported IBS-like symptoms, and 5.0% had IBS according to Rome IV-criteria. Indigestion was the most common GI symptom (24.2%). Females had a higher total mean score of GI symptoms ( p = 0.021), with higher frequencies of constipation ( p = 0.006) and abdominal pain ( p = 0.031), compared to males. Males had higher concentration of total faecal SCFAs ( p = 0.004) and all major SCFAs compared to females. Total faecal SCFAs were negatively associated with constipation, independently of dietary fibre intake, total energy intake, sex and BMI (B = − 0.006, 95% CI [− 0.009, − 0.004], p < 0.001). We observed a positive correlation between total faecal SCFA concentrations and diarrhoea ( r = 0.072, p = 0.039) and looser stool consistency ( r = 0.185, p < 0.001); however, these associations did not persist in the regression analyses. All GI symptoms positively correlated with increasing BMI. Conclusion: GI symptoms are common in older adults, and IBS is at least as prevalent as observed in the general adult population. Improving dietary habits and preventing overweight and obesity may reduce the risk of GI symptoms and improve gut health in older adults.

  • Heterogeneity in postprandial glucose-insulin and triacylglycerol dynamics and associations with plasma metabolome and body composition in obesity

    by Nikolai B. Aunbakk, Siv Kjølsrud Bøhn, Johnny Laupsa-Borge, Cathrine Sommersten, Adrian McCann, Gülen Arslan Lied, Ottar Nygård, Jutta Dierkes, Gunnar Mellgren, Simon N. Dankel, et al.

    Functional principal component analysis (FPCA) revealed large individual and sex-specific differences in postprandial glucose, C-peptide, and triacylglycerol dynamics in obesity. Although the primary postprandial patterns correlated strongly with the area under the curve (AUC), the presence and timing of peaks varied independently of AUC. Over 40% of participants showed nonsynchronized postprandial glucose and C-peptide curves. High and delayed peaks were associated with markers of insulin resistance, altered amino acid metabolism, visceral adiposity, and liver dysfunction.


  • Open Access

    Maternal intake of dietary protein from plant and animal sources and development of pharmacologically treated hypertension within 10 years after pregnancy

    by Jannike Øyen, Anne Lise Brantsæter, Lene S Myrmel, Hanne Rosendahl-Riise, Ottar Nygård, Eva Gerdts, Lise Madsen, Grace M Egeland

    Aims: To investigate associations between intake of protein from plant and animal sources and risk of development of pharmacologically treated hypertension (defined as antihypertensive medication usage >90 days after delivery) in a large population of Norwegian mothers followed up to 10 years after delivery. Methods and results: Women in the Norwegian Mother, Father and Child Cohort Study (MoBa) recruited between 2004–2008 were linked to the Norwegian Prescription Database (2004–2013) to ascertain antihypertensive medication usage. Women with hypertension before pregnancy were excluded, leaving 59 967 mothers for analyses. Diet was assessed by a validated semi-quantitative food frequency questionnaire in mid-pregnancy. Cox proportional hazard analyses evaluated HRs and 95% CIs for quintiles of intake in multivariable models. A total of 1480 (2.5%) women developed hypertension within 10 years of follow-up. Intake of protein from dairy, particularly milk/yoghurt, was inversely associated with hypertension (HR for highest vs. lowest milk/yoghurt quintile: 0.76, 95% CI 0.65, 0.89, P-trend < 0.001). Intake of red meat protein was positively associated with hypertension (HR for quintile four vs. quintile one: 1.27, 95% CI 1.07, 1.51, P-trend = 0.010). No significant associations were observed for plant-based protein sources. Conclusion: The findings suggest that intake of protein from dairy sources is inversely associated with hypertension, while protein from red meat is positively associated with developing hypertension up to ten years after pregnancy. This study provides novel contributions to the literature by examining the impact of a diverse array of plant and animal protein sources on the risk of hypertension in women. Lay summary: This study examined the relationship between protein intake from plant and animal sources and the risk of developing hypertension in Norwegian mothers within 10 years after pregnancy.Consumption of protein from dairy products, especially milk and yoghurt, was inversely associated with hypertension.Intake of red meat protein was positively associated with hypertension.


  • Open Access

    Kynurenine Pathway Metabolites in the Blood and Cerebrospinal Fluid Are Associated with Human Aging

    by Stein-Erik H. Solvang, Allison Hodge, Leiv Otto Watne, Otavio Cabral-Marques, Jan Erik Nordrehaug, Graham G. Giles, Pierre-Antoine Dugué, Ottar Nygård, Per Magne Ueland, Adrian McCann, et al.

    The kynurenine pathway is implicated in aging, longevity, and immune regulation, but longitudinal studies and assessment of the cerebrospinal fluid (CSF) are lacking. We investigated tryptophan (Trp) and downstream kynurenine metabolites and their associations with age and change over time in four cohorts using comprehensive, targeted metabolomics. The study included 1574 participants in two cohorts with repeated metabolite measurements (mean age at baseline 58 years ± 8 SD and 62 ± 10 SD), 3161 community‐dwelling older adults (age range 71‐74 years), and 109 CSF donors (mean age 73 years ± 7 SD). In the first two cohorts, age was associated with kynurenine (Kyn), quinolinic acid (QA), and the kynurenine to tryptophan ratio (KTR), and inversely with Trp. Consistent with these findings, Kyn, QA, and KTR increased over time, whereas Trp decreased. Similarly, QA and KTR were higher in community‐dwelling older adults of age 74 compared to 71, whereas Trp was lower. Kyn and QA were more strongly correlated with age in the CSF compared to serum and increased in a subset of participants with repeated CSF sampling (n = 33) over four years. We assessed associations with frailty and mortality in two cohorts. QA and KTR were most strongly associated with mortality and frailty. Our study provides robust evidence of changes in tryptophan and kynurenine metabolism with human aging and supports links with adverse health outcomes. Our results suggest that aging activates the inflammation and stress‐driven kynurenine pathway systemically and in the brain, but we cannot determine whether this activation is harmful or adaptive. We identified a relatively stronger age‐related increase of the potentially neurotoxic end‐product QA in brain.


  • Open Access

    Plasma hydroxyanthranilic acid as a predictor of stress induced myocardial ischemia in non-obstructive coronary artery disease

    by I Karaji, M T Lonnebakken, S Storesund, I Khan, P M Ueland, K Vikenes, O K Nygard, E R Pedersen

    Background: The tryptophan catabolite hydroxyanthranilic acid (HAA) has potent immunomodulatory and vasoactive effects. HAA is also a precursor in the synthesis of nicotinamide adenine dinucleotide (NAD), a crucial cofactor in energy-metabolism. We have previously demonstrated that elevated plasma HAA predicted risk of myocardial infarction. Purpose: To explore if plasma HAA is associated with stress induced myocardial ischemia in non-obstructive coronary artery disease (CAD). Methods: In 132 patients with chest pain and non-obstructive CAD by coronary computed tomography angiography (CCTA), plasma HAA was analyzed by gas chromatography tandem mass spectrometry. All participants underwent myocardial contrast stress echocardiography. Myocardial ischemia was assessed as delayed contrast replenishment at peak dobutamine stress during real-time low mechanical index imaging and destruction replenishment. The extent of ischemia was defined as the number of segments with delayed contrast enhancement using a 17-segment left ventricular model. Associations of plasma HAA with myocardial ischemia was evaluated in a multivariate adjusted linear regression model. Results: Mean (SD) age at inclusion was 63 (8) years and 56% were women. At CCTA, the median (25th, 75th percentile) coronary artery calcium (CAC) score was 42 (13–107) Agatston units, whereas the mean (SD) segment involvement score (SIS) was 2.6 (1.6). Myocardial ischemia was found in 52% of patients with on average 5 (3) ischemic segments per patient. Serum HAA did not correlate with the CAC score or SIS (p>0.29). After multivariate adjustment including age, sex, body mass index, systolic blood pressure, diabetes, current smoking, and LDL cholesterol, the odds ratio and 95% confidence interval for myocardial ischemia was 1.55 (1.04–2.32), P=0.03, per SD increment of plasma HAA levels (log transformed). Plasma HAA was also associated with the extent of myocardial ischemia with a multivariate adjusted β of 0.26, P=0.004. Conclusion: Plasma HAA is associated with the extent of myocardial ischemia in non-obstructive CAD. Potential roles of this metabolite in atherogenesis, vascular dysfunction and as a predictor of myocardial ischemia should be further elucidated. Funding Acknowledgement: Type of funding sources: Public hospital(s). Main funding source(s): Western Norway Regional Health Authority

  • Open Access

    The association between dairy intake and risk of cardiovascular disease and mortality in patients with stable angina pectoris

    by Anthea Van Parys, Jostein Sæle, Nathalie G Puaschitz, Åslaug Matre Anfinsen, Therese Karlsson, Thomas Olsen, Teresa R Haugsgjerd, Kathrine J Vinknes, Kirsten B Holven, Jutta Dierkes, et al.

    Aims: The association of dairy products with cardiovascular disease and mortality risk remains heavily debated. We aimed to investigate the association between intake of total dairy and dairy products and the risk of acute myocardial infarction (AMI), stroke, and cardiovascular and all-cause mortality. Methods and results: We included 1929 patients (80% men, mean age 62 years) with stable angina pectoris from the Western Norway B-vitamin Intervention Trial. Dietary data were obtained via a 169-item food frequency questionnaire. Risk associations were estimated using Cox proportional hazard regression models adjusted for relevant covariates. Non-linear associations were explored visually. The mean (±SD) dairy intake in the study population was 169 ± 108 g/1000 kcal. Median follow-up times were 5.2, 7.8, and 14.1 years for stroke, AMI, and mortality, respectively. Higher intake of total dairy and milk were positively associated with stroke risk [HR (95% CI): 1.14 (1.02, 1.27) and 1.13 (1.02, 1.27), cardiovascular mortality 1.06 (1.00, 1.12) and 1.07 (1.01, 1.13)] and all-cause mortality [1.07 (1.03, 1.11) and 1.06 (1.03, 1.10)] per 50 g/1000 kcal. Higher cheese intake was inversely associated with AMI risk [0.92 (0.83, 1.02)] per 10 g/1000 kcal. Butter was associated with increased AMI risk [1.10 (0.97, 1.24)] and all-cause mortality [1.10 (1.00, 1.20) per 5 g/1000 kcal. Conclusion: Higher dairy and milk consumption were associated with increased risk of mortality and stroke. Cheese was associated with decreased, and butter with increased, risk of AMI. Dairy is a heterogenous food group with divergent health effects and dairy products should therefore be investigated individually.


  • Open Access

    Assessment of Dietary Choline Intake, Contributing Food Items, and Associations with One-Carbon and Lipid Metabolites in Middle-Aged and Elderly Adults: The Hordaland Health Study

    by Anthea Van Parys, Maria Sandvik Brække, Therese Karlsson, Kathrine J Vinknes, Grethe S Tell, Teresa R Haugsgjerd, Per Magne Ueland, Jannike Øyen, Jutta Dierkes, Ottar Nygård, et al.

    Background Choline is an essential nutrient for humans and is involved in various physiologic functions. Through its metabolite betaine, it is closely connected to the one-carbon metabolism, and the fat-soluble choline form phosphatidylcholine is essential for VLDL synthesis and secretion in the liver connecting choline to the lipid metabolism. Dietary recommendations for choline are not available in the Nordic countries primarily due to data scarcity. Objectives The aim of this study was to investigate the dietary intake of total choline and individual choline forms, dietary sources, and the association of total choline intake with circulating one-carbon metabolites and lipids. Methods We included 5746 participants in the Hordaland Health Study, a survey including community-dwelling adults born in 1925-1927 (mean age 72 y, 55% women) and 1950-1951 (mean age 48 y, 57% women). Dietary data were obtained using a 169-item FFQ, and choline content was calculated using the USDA Database for Choline Content of Common Foods, release 2. Metabolites of the one-carbon and lipid metabolism were measured in a nonfasting blood sample obtained at baseline, and the association with total choline intake was assessed using polynomial splines. Results The geometric mean (95% prediction interval) energy-adjusted total choline intake was 260 (170, 389) mg/d, with phosphatidylcholine being the main form (44%). The major food items providing dietary choline were eggs, low-fat milk, potatoes, and leafy vegetables. Dietary total choline was inversely associated with circulating concentrations of total homocysteine, glycine, and serine and positively associated with choline, methionine, cystathionine, cysteine, trimethyllysine, trimethylamine-N-oxide, and dimethylglycine. A weak association was observed between choline intake and serum lipids. Conclusions Phosphatidylcholine was the most consumed choline form in community-dwelling adults in Norway. Our findings suggest that choline intake is associated with the concentration of most metabolites involved in the one-carbon and lipid metabolism.


  • Primary cardiovascular risk prediction by LDL-cholesterol in Caucasian middle-aged and older adults: a joint analysis of three cohorts

    by Mika Hilvo, Indu Dhar, Mitja Lääperi, Vegard Lysne, Gehard Sulo, Grethe S Tell, Pekka Jousilahti, Ottar K Nygård, Hermann Brenner, Ben Schöttker, et al.

    Aims: Low-density lipoprotein cholesterol (LDL-C) is an established causal driver of atherosclerotic cardiovascular disease (ASCVD), but its performance and age-dependency as a biomarker for incident events and mortality arising from ASCVD is less clear. The aim was to determine the value of LDL-C as a susceptibility/risk biomarker for incident coronary heart disease (CHD), ASCVD, and stroke events and deaths, for the age groups <50 and ≥50 years.Methods and results: The performance of LDL-C was evaluated in three cohorts, FINRISK 2002 (n = 7709), HUSK (n = 5431), and ESTHER (n = 4559), by Cox proportional hazards models, C-statistics, and net reclassification index calculations. Additionally, the hazard ratios (HRs) for the three cohorts were pooled by meta-analysis. The most consistent association was observed for CHD [95% confidence interval (CI) for HRs per standard deviation ranging from 0.99 to 1.37], whereas the results were more modest for ASCVD (0.96–1.18) due to lack of association with stroke (0.77–1.24). The association and discriminatory value of LDL-C with all endpoints in FINRISK 2002 and HUSK were attenuated in subjects 50 years and older [HRs (95% CI) obtained from meta-analysis 1.11 (1.04–1.18) for CHD, 1.15 (1.02–1.29) for CHD death, 1.02 (0.98–1.06) for ASCVD, 1.12 (1.02–1.23) for ASCVD death, and 0.97 (0.89–1.05) for stroke].Conclusion: In middle-aged and older adults, associations between LDL-C and all the studied cardiovascular endpoints were relatively weak, while LDL-C showed stronger association with rare events of pre-mature CHD or ASCVD death among middle-aged adults. The predictive performance of LDL-C also depends on the studied cardiovascular endpoint.


  • Open Access

    Clinical risk scores identify more patients at risk for cardiovascular events within 30 days as compared to standard ACS risk criteria: the WESTCOR study

    by Ole-Thomas Steiro, Hilde L Tjora, Jørund Langørgen, Rune Bjørneklett, Ottar K Nygård, Øyvind Skadberg, Vernon V S Bonarjee, Bertil Lindahl, Torbjørn Omland, Kjell Vikenes, et al.

    Aims: Troponin-based algorithms are made to identify myocardial infarctions (MIs) but adding either standard acute coronary syndrome (ACS) risk criteria or a clinical risk score may identify more patients eligible for early discharge and patients in need of urgent revascularization. Methods and results: Post-hoc analysis of the WESTCOR study including 932 patients (mean 63 years, 61% male) with suspected NSTE-ACS. Serum samples were collected at 0, 3, and 8–12 h and high-sensitivity cTnT (Roche Diagnostics) and cTnI (Abbott Diagnostics) were analysed. The primary endpoint was MI, all-cause mortality, and unplanned revascularizations within 30 days. Secondary endpoint was non-ST-elevation myocardial infarction (NSTEMI) during index hospitalization. Two combinations were compared: troponin-based algorithms (ESC 0/3 h and the High-STEACS algorithm) and either ACS risk criteria recommended in the ESC guidelines, or one of eleven clinical risk scores, HEART, mHEART, CARE, GRACE, T-MACS, sT-MACS, TIMI, EDACS, sEDACS, Goldman, and Geleijnse–Sanchis. The prevalence of primary events was 21%. Patients ruled out for NSTEMI and regarded low risk of ACS according to ESC guidelines had 3.8–4.9% risk of an event, primarily unplanned revascularizations. Using HEART score instead of ACS risk criteria reduced the number of events to 2.2–2.7%, with maintained efficacy. The secondary endpoint was met by 13%. The troponin-based algorithms without evaluation of ACS risk missed three-index NSTEMIs with a negative predictive value (NPV) of 99.5% and 99.6%. Conclusion: Combining ESC 0/3 h or the High-STEACS algorithm with standardized clinical risk scores instead of ACS risk criteria halved the prevalence of rule-out patients in need of revascularization, with maintained efficacy.